Norfloxacin blood-brain barrier transport in rats is not affected by probenecid coadministration

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 1, 2006, Pages 371-373

  Marchand, Sandrine ^a,b   Forsell, Anna ^a   Chenel, Marylore ^a,c   Comets, Emmanuelle ^d   Lamarche, Isabelle ^a   Couet, William ^a,b,e  

^a Faculte de Medicine et de Pharmacie   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d BICHAT HOSPITAL   (France)

^e Pole Biologie Sante   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NORFLOXACIN; PROBENECID; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG TRANSPORT; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; DRUG INTERACTIONS; MALE; MICRODIALYSIS; NORFLOXACIN; PROBENECID; RATS; RATS, SPRAGUE-DAWLEY;

EID: 29944434454     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.1.371-373.2006     Document Type: Article

References (17)

1. Beal, S. L., and L. B. Sheiner. 1992. (ed.) NONMEM users' guides-part VII. NONMEM Project Group, University of California, San Francisco, Calif.
2. Chenel, M., S. Marchand, A. Dupuis, I. Lamarche, J. Paquereau, C. Pariat, and W. Couet. 2004. Simultaneous central nervous system distribution and pharmacokinetic/pharmacodynamic modeling of the electroencephalogram effect of norfloxacin administered at a convulsant dose in rats. Br. J. Pharmacol. 142:323-330.
3. Christ, W. 1990. Central nervous system toxicity of quinolones: human and animal findings. J. Antimicrob. Chemother. 26:219-225.
4. Davis, J. D., L. Aarons, and J. B. Houston. 1995. Effect of norfloxacin on theophyllin disposition: a comparison with other fluoroquinolones. Pharm. Res. 12:257-262.
5. Delon, A., S. Bouquet, F. Huguet, V. Brunet, P. Courtois, and W. Couet. 1999. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of fluoroquinolones in rats. Antimicrob. Agents Chemother. 43:1511-1515.
6. Delon, A., F. Huguet, P. Courtois, J. M. Vierfond, S. Bouquet, and W. Couet. 1997. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of pefloxacin and norfloxacin in rats. J. Pharmacol. Exp. Ther. 280:983-987.
7. De Sarro, A., and G. De Sarro. 2001. Adverse reactions to fluoroquinolones. An overview on mechanistic aspects. Curr. Med. Chem. 8:371-384.
8. Foote, E. F., and C. E. Halstenson. 1998. Effects of probenecid and cimetidine on renal disposition of ofloxacin in rats. Antimicrob. Agents Chemother. 42:456-458.
9. Marchand, S., M. Chenel, I. Lamarche, C. Pariat, and W. Couet. 2003. Dose ranging pharmacokinetics and brain distribution of norfloxacin using microdialysis in rats. J. Pharm. Sci. 92:2467-2474.
10. Marchand, S., C. Dahyol, I. Lamarche, O. Mimoz, and W. Couet. 2005. Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fluids of noninfected rats. Antimicrob. Agents Chemother. 49:2356-2361.
11. Panhard, X., and F. Mentre. 2005. Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials. Stat. Med. 24:1509-1524.
12. Shimada, J., T. Yamaji, Y. Ueda, H. Uchida, H. Kusajima, and T. Irikura. 1983. Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans. Antimicrob. Agents Chemother. 23:1-7.
13. Sugiyama, D., H. Kushuara, Y. Shitara, T. Abe, P. T. Meier, T. Sekine, H. Endou, H. Suzuki, and Y. Sugiyama. 2001. Characterization of the efflux transport of 17β-estradiol-D-17β-glucuronide from the brain across the blood-brain-barrier. J. Pharmacol. Exp. Ther. 298:316-322.
14. Tunblad, K., E. N. Jonsson, and M. Hammarlund-Udenaes. 2003. Morphine blood-brain barrier transport is influenced by probenecid co-administration. Pharm. Res. 20:618-623.
15. Wahlby, U., E. N. Jonsson, and M. O. Karlsson. 2001. Assessment of actual significance levels for covariate effects in NONMEM. J. Pharmacokinet. Pharmacodyn. 28:231-252.
16. Wong, S. L., K. Van Belle, and R. J. Sawchuck. 1993. Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid/cerebrospinal fluid in the rabbit: investigation of the inhibitory effect of probenecid using microdialysis. J. Pharmacol. Exp. Ther. 264:899-909.
17. Xie, R., M. R. Bouw, and M. Hammarlund-Udenaes. 2000. Modelling of the blood-brain barrier transport of morphine-3-glucuronide studied using microdialysis in the rat: involvement of probenecid-sensitive transport. Br. J. Pharmacol. 131:1784-1792.